HEALTHCARE PROFESSIONALS

About Vencarm XL

Welcome to vencarm.co.uk

Vencarm XL is a prolonged-release capsule of venlafaxine indicated for the:1

  • Treatment of major depressive episodes

  • Prevention of recurrence of major depressive episodes

  • Treatment of generalised anxiety disorder

  • Treatment of social anxiety disorder

  • Treatment of panic disorder, with or without agoraphobia

Available as:

  • 37.5mg prolonged-release capsules

  • 75mg prolonged-release capsules

  • 150mg prolonged-release capsules

  • 225mg prolonged-release capsules

Vencarm XL is bioequivalent to the originator EFEXOR XL (venlafaxine prolonged-release capsules) (Pfizer Ltd) based on biostudies using TREVILOR® retard (Venlafaxine Hydrochloride Prolonged-release) Capsules, (Pfizer Pharma GmbH, Germany)2

Vencarm XL could offer significant cost savings to your practice and clinical commissioning group (CCG).

venlafaxine 37.5mg, 75mg, 150mg and 225mg prolonged-release capsules are in category C of the UK Drug Tariff.3

However, the NHS could make up to 79% savings on the cost of category C venlafaxine by prescribing Vencarm XL by brand name.3*

Vencarm XL is one of Aspire Pharma’s cost saving prolonged-release products.

Quite simply a wholesale switch of venlafaxine prolonged-release 37.5mg, 75mg, 150mg and 225mg tablet and capsule prescriptions to Vencarm XL could save an average CCG £35,167 per year.4***

In addition:

  • Full range of strengths available for Vencarm XL;

  • Available from mainline wholesalers;

  • High level of stockholdings;

  • Bioequivalent to the originator brand;2

  • Price guaranteed**

*Based on up to 79% saving on the cost of Category C venlafaxine XL capsules and tablets in the UK Drug Tariff. **No change in price subject to no material change to the products or Category C of the UK Drug Tariff until the 2024 PPRS review. ***Savings based on market data in reference 4. Savings calculated from 2018 spend for 217 CCGs switching their generic and originator brand 37.5mg, 75mg, 150mg and 225mg venlafaxine prolonged-release tablets and capsules prescriptions to Vencarm XL.
References 1) Vencarm XL SmPCs. 2) Data on file. 1010344221 v 2.0 September 2019. 3) March 2020 UK Drug Tariff. 4) ePact data Jan-Dec 2018

TRUSTED BRANDS.
DEPENDABLE SUPPLY CHAIN.

For further information please call: 01730 231148,
email: info@aspirepharma.co.uk or visit www.aspirepharma.co.uk
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148

For more information about Vencarm XL (venlafaxine), please see the abbreviated prescribing information.

Revision reference – Vencarm XL_6_25.08.2020

More products available
in this range:
Click to view their
individual websites